Nimenrix

Nimenrix (Brain Protective Vaccine) is a 4-valent conjugate vaccine against meningococcus, aiming at serotypes A, C, W135 and Y. Six-week-old newborn babies are vaccinated, only one needle is needed for a one-year-old or older, and there is no age limit, so long-term protection can be obtained. Brain vaccine is the only meningococcal 4-valent conjugate vaccine approved by the European Drug Administration and the Hong Kong Health Department for the vaccination of newborn infants in Hong Kong. It has been registered in more than 60 countries and regions worldwide and has been widely approved. If meningococcal polysaccharide vaccine has been vaccinated, it can also be used as a reinforcement agent. Protect your beloved and act now!

Free Trial